Latest News
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Gold remains firmly bullish, holding above $4220 with momentum indicators supportive of further gains.
Via Talk Markets · December 8, 2025
Why Did Structure Therapeutics Stock Surge Pre-Market Today?stocktwits.com
Via Stocktwits · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
The surplus in the oil market is set to grow in 2026, following OPEC+'s decision to unwind supply cuts at a quicker-than-expected pace.
Via Talk Markets · December 8, 2025
Paramount launched an all-cash tender offer to acquire Warner Bros. for $30/share, valuing the company at $108.4B and promising $6B+ in cost synergies.
Via Benzinga · December 8, 2025
Investor confidence in the crypto mining space, and Bitfarms, appears to be on shakier ground this week.
Via The Motley Fool · December 8, 2025
Archer-Daniels-Midland has outperformed the Consumer Staples sector over the past year, but analysts are cautious about the stock’s prospects.
Via Barchart.com · December 8, 2025
Kymera Therapeutics released positive clinical results for KT-621 for atopic dermatitis and other allergic diseases.
Via Benzinga · December 8, 2025
The AUD/USD outlook remains constructive as the US dollar weakens ahead of the Fed rate cut.
Via Talk Markets · December 8, 2025
There's no point in life when your credit score stops mattering.
Via The Motley Fool · December 8, 2025
Xcel Energy has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.
Via Barchart.com · December 8, 2025
Rosenblatt Securities downgraded Netflix to ‘Neutral’ from ‘Buy’, citing concerns about the uncertainty and risks following the acquisition.
Via Stocktwits · December 8, 2025
Elon Musk nixes reports that SpaceX is targeting an $800 billion valuation via a secondary stock sale. But is a 2026 IPO in play?
Via Investor's Business Daily · December 8, 2025
Via Benzinga · December 8, 2025
Via Benzinga · December 8, 2025
Tractor Supply has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Via Barchart.com · December 8, 2025
Wave Life Sciences stock shot a year-high Monday on promising results for an entirely new drug that could target fat loss.
Via Investor's Business Daily · December 8, 2025
Coinbase Inc.
Via Benzinga · December 8, 2025
Despite Dollar General's strong performance relative to the broader Nasdaq Composite over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.
Via Barchart.com · December 8, 2025
These three dividend stocks are poised to rally in the new year.
Via The Motley Fool · December 8, 2025
Via Benzinga · December 8, 2025
The Aussie has been gaining some strength in the days ahead of the RBA rate decision, thanks to improving commodity prices.
Via Talk Markets · December 8, 2025
Early ASH 2025 data shows Incyte's INCA033989 delivers spleen, anemia and symptom improvements in mutCALR myelofibrosis.
Via Benzinga · December 8, 2025
Kymera Therapeutics could have the next Dupixent, analysts said Monday, as shares skyrocketed on a promising test in eczema.
Via Investor's Business Daily · December 8, 2025
Saylor revealed that he is in talks with sovereign wealth funds and hedge funds to expand adoption.
Via Stocktwits · December 8, 2025
Broadcom stock rose and Marvell stock fell Monday on a disputed report that Microsoft is in talks to move its custom chip business.
Via Investor's Business Daily · December 8, 2025
Via MarketBeat · December 8, 2025
Virco Mfg. reports Q3 2025 loss, missing revenue and earnings estimates amid a cyclical downturn in education furniture demand.
Via Chartmill · December 8, 2025
One luxury resale stock is quietly delivering its strongest growth in years — despite insiders taking some profits.
Via The Motley Fool · December 8, 2025
Applied Materials is nearing its 52-week high, driven by strong momentum despite mixed fundamentals, as investors await upcoming earnings results related to semiconductor demand.
Via Talk Markets · December 8, 2025
You need to know about this before the 2025 tax season gets underway.
Via The Motley Fool · December 8, 2025
Paramount is offering $30 per share in cash, and the company stated that the proposed transaction is for the entirety of WBD, including the Global Networks segment.
Via Stocktwits · December 8, 2025
Carvana joins S&P 500, making Viking Global's Andreas Halvorsen and Coatue's Philippe Laffont potential paper profit of $540 million.
Via Benzinga · December 8, 2025
American Electric Power has outperformed the Dow Jones index over the past year. Moreover, Wall Street analysts remain moderately optimistic about its prospects.
Via Barchart.com · December 8, 2025
Via Benzinga · December 8, 2025
CoreWeave Inc (NASDAQ:CRWV) shares are trading lower Monday after the company announced a proposed offering of convertible senior notes.
Via Benzinga · December 8, 2025
With three-and-a-half weeks of trading left for 2025, all the major asset classes are holding on to gains, based on a set of ETFs.
Via Talk Markets · December 8, 2025
Morgan Stanley analyst Andrew Percoco downgraded Rivian to ‘Underweight’ from ‘Equal Weight’, maintaining a $12 price target.
Via Stocktwits · December 8, 2025
Via Benzinga · December 8, 2025
ONEOK has underperformed other midstream energy stocks over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.
Via Barchart.com · December 8, 2025
ServiceNow Inc. (NYSE: NOW) pledges $110 million for AI adoption in Canada, including 100 new jobs and a local data center.
Via Benzinga · December 8, 2025
The company said Monday patients who took its obesity treatment lost up to 15.3% more weight than placebo recipients.
Via Investor's Business Daily · December 8, 2025